Search clinical trials for: antibody-drug conjugate therapy
Total 13131 results
-
Public Health EnglandCompletedPneumococcal Infections | Meningococcal InfectionsUnited Kingdom
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
MedImmune LLCCompletedLymphoma | LeukemiaUnited States
-
Central South UniversityCompletedAgranulocytosis | Opportunistic Infections | Sepsis (SMQ)China
-
Public Health EnglandInstitute of Child Health; National Institute of Biological Standards and ControlCompletedPneumococcal Infections | Meningococcal InfectionsUnited Kingdom
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
Ambrx, Inc.CompletedBreast Neoplasms | Solid Tumors | Gastric NeoplasmUnited States, Australia
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
Hangzhou DAC Biotechnology Co., Ltd.Not yet recruitingAdvanced Solid Tumors | Hematological Malignancies
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...RecruitingAdvanced/ Metastatic Solid TumorsChina
-
Mersana TherapeuticsGOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian CancerUnited States, Australia, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
MBrace TherapeuticsRecruiting
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...RecruitingAdvanced and Metastatic Solid TumorChina
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustCompletedAtaxia Telangiectasia (AT)United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeningitis | Meningococcal InfectionCanada
-
Sorrento Therapeutics, Inc.Not yet recruitingAdvanced Solid TumorUnited States
-
Bio-Thera SolutionsNot yet recruiting
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
Oxford BioTherapeutics LtdRecruitingSolid TumorUnited States, Belgium, Spain, France, Greece
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Leiden University Medical CenterRecruitingVaccine-Preventable DiseasesNetherlands
-
Seoul National University HospitalDong-A Pharmaceutical Co., Ltd.TerminatedSystolic Heart FailureKorea, Republic of
-
Northwestern UniversitySeagen Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedEsophageal Cancer | Non-Small Cell Lung Cancer | Metastatic Solid TumorsUnited States, Canada
-
The Hospital for Sick ChildrenCompleted
-
National Taiwan University HospitalNational Science Council, TaiwanUnknown
-
Sorrento Therapeutics, Inc.WithdrawnLight Chain (AL) Amyloidosis
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Seagen Inc.WithdrawnHematopoietic/Lymphoid CancerUnited States
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bUnited Kingdom
-
RemeGen Co., Ltd.Active, not recruitingBiliary Tract CancerChina
-
RemeGen Co., Ltd.Completed
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cambridge Antibody TechnologyUnknownLeukemia | Non-Hodgkin's Lymphoma | NHLUnited States, Poland
-
RemeGen Co., Ltd.RecruitingGynecological MalignancyChina
-
RemeGen Co., Ltd.CompletedGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingFollicular Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Diffuse Large-Cell Lymphoma | Transformed Follicular Lymphoma (TFL) | High-grade B-cell Lymphoma (HGBCL)United States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Laura Huppert, MD, BAAmbrx, Inc.Not yet recruitingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerTriple Negative Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerUnited States
-
RemeGen Co., Ltd.RecruitingAdvanced Melanoma | Melanoma, Stage II | HER2-positiveChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid Tumor, Protocol Specific
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina